^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Mesothelioma |
| Drug: | carboplatin (Tubulin polymerization promoter) + pemetrexed (Thymidylate synthase inhibitor, THF dehydrogenase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Malignant Peritoneal Mesothelioma…FIRST-LINE SYSTEMIC THERAPY…Preferred…Pemetrexed…Cisplatin…or carboplatin
